Technical Data
Bacillus anthracis (Anthrax)
Anthrax toxin plays a major role in the pathogenesis of anthrax. Virulent strains of Bacillus anthracis produce a complex exotoxin with 3 distinct antigenic components: the edema factor (EF), the protective antigen or binding domain (PA), and the lethal factor (LF).

Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Recommended Antibody Pair:
B0003-05E,B0003-05D (detection): Bacillus anthracis (Anthrax).
Capture: B0003-05

Hybridization of Sp2/0 myeloma cells with spleen cells from Balb/c mice.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage, aliquot and store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
MabIgG2b1.B.10DAffinity Purified
500ug4C (-20C Glycerol)Blue IceMouse
Purified protective antigen from inactivated Bacillus anthracis culture (vaccine strain STI-1).
Purified by Protein G Sepharose chromatography (> 95%).
Supplied as a liquid in PBS, pH 7.4, 0.09% sodium azide before the addition of glycerol to 40%.
Recognizes Protective Antigen of Bacillus anthracis. Does not crossreact with Lethal Factor Antigen of B. anthracis, Y. Pestis, F. Tularensis and Toxoplasma gondii.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.